TM London Day One
Wednesday, 6th December 2017
15.10 | Developing an In Vivo model for Proof of Concept of small molecules targeting the myeloid compartment
I received my PhD in functional morphology from Department of Zoology at Lund University, Sweden. I have more than 15 years of experience from the Pharmaceutical and Biotech industry within the areas of autoimmunity, inflammation and oncology. I´m currently Head of Pharmacology at Active Biotech AB, a biotechnology company based in Lund and focused on development of pharmaceutical products within the immuno-oncology area. In my current research I utilize syngeneic and humanized models to investigate how the interaction of immune cells can be modulated by small molecule compounds to inhibit tumor growth and metastasis.